A Phase I Clinical Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetic Characteristics of Oral Deuremidevir Hydrobromide for Suspension in Chinese Healthy Volunteers
Latest Information Update: 16 Oct 2023
At a glance
- Drugs Deuremidevir hydrobromide (Primary) ; Deuremidevir hydrobromide (Primary)
- Indications COVID 2019 infections
- Focus Pharmacokinetics
- Sponsors Vigonvita Life Sciences
Most Recent Events
- 11 Oct 2023 Status changed from recruiting to completed.
- 04 Aug 2023 Planned primary completion date changed from 1 Aug 2023 to 1 Sep 2023.
- 04 Aug 2023 Status changed from not yet recruiting to recruiting.